Researcher
Filip Van den Bosch
- Keywords:Psoriatic arthritis, Biological DMARDs, Spondyloarthritis, Rheumatoid arthritis, Targeted Synthetic DMARDs, Ankylosing spondylitis
- Disciplines:Immunomodulation therapy, Other clinical sciences not elsewhere classified
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2011 → 30 Sep 2018
Projects
1 - 5 of 5
- Microbes-4-Immunity: single-cell based sorting and investigation of the functional microbiome in intestinal and extra-intestinal immune homeostasis.From1 Jan 2022 → TodayFunding: BOF - projects
- Deciphering the functional phenotype of ?d T cells in spondyloarthritis.From1 Nov 2021 → TodayFunding: FWO fellowships
- Role of intestinal barrier dysfunction for the pathogenesis of spondyloarthritisFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Dynamic modulation of disease progression in chronic gut and joint inflammation in spondyloarthritidesFrom1 Jan 2017 → 31 Oct 2022Funding: BOF - Concerted Research Project from 1994
- Relation between inflammation of the gut and arthritis in spondyloarthropathy: cellular mechanisms and therapeutical implicationsFrom1 Jan 2007 → 31 Oct 2012Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 214
- Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients(2024)
Authors: Manouk de Hooge, Alla Ischenko, Serge Steinfeld, Adrien Nzeusseu, Dirk Elewaut, Rik Lories, Filip Van den Bosch, Kurt De Vlam
Pages: 194 - 198 - Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response(2023)
Authors: Anna Molto, Desiree van der Heijde, Filip Van den Bosch, Maxime Dougados
- EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis(2023)
Authors: Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Annamaria Iagnocco, Paolo Gisondi, Peter Balint, Heidi Bertheussen, Wolf-Henning Boehncke, et al.
Pages: 1162 - 1170 - Efficacy and safety of risankizumab for active psoriatic arthritis : 52-week results from the KEEPsAKE 2 study(2023)
Authors: Andrew Ostor, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Wenjing Lu, Zailong Wang, Ahmed M. Soliman, Ann Eldred, et al.
Pages: 2122 - 2129 - Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA : post-hoc analysis of the CRESPA trial(2023)
Authors: Simon Krabbe, Thomas Renson, Lennart Jans, Dirk Elewaut, Filip Van den Bosch, Philippe Carron, Mikkel Østergaard
Pages: 2130 - 2138 - Cardiovascular comorbidities in psoriatic arthritis : epidemiology and risk factors in two different European populations(2023)
Authors: Silvia Scriffignano, Rik Lories, Adrien Nzeusseu Toukap, Ennio Lubrano, Francesco Ciccia, Serge Steinfeld, Fabio Massimo Perrotta, Ilenia Pantano, Filip Van den Bosch, Kurt de Vlam
Pages: 1815 - 1822 - Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate‐like T cell signature(2023)
Authors: Céline Mortier, Katrien Quintelier, Ann-Sophie De Craemer, Thomas Renson, Liselotte Deroo, Emilie Dumas, Eveline Verheugen, Julie Coudenys, Tine Decruy, Zuzanna Łukasik, et al.
Pages: 1969 - 1982 - Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis(2023)
Authors: Koen Venken, Matthias Jarlborg, Tine Decruy, Céline Mortier, Carolien Vlieghe, Elisabeth Gilis, Ann-Sophie De Craemer, Julie Coudenys, Isabelle Cambré, Devan Fleury, et al.
Pages: 1076 - 1090 - Machine learning pipeline for predicting bone marrow edema along the sacroiliac joints on magnetic resonance imaging(2023)
Authors: Joris Roels, Ann-Sophie De Craemer, Thomas Renson, Manouk de Hooge, Arne Gevaert, Thomas Van Den Berghe, Lennart Jans, Nele Herregods, Philippe Carron, Filip Van den Bosch, et al.
Pages: 2169 - 2177 - Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics : 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study(2023)
Authors: Philip Mease, Arathi Setty, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Mauro Keiserman, Kyle Carter, Yihan Li, Reva McCaskill, Erin McDearmon-Blondell, et al.
Pages: 2286 - 2297